POSSIBILITIES OF ORGAN-PRESERVING TREATMENT OF PATIENTS WITH MULTIPLE RENAL TUMORS

Renal cell carcinoma (RCC) occupies one of the leading places in the world for morbidity among malignant neoplasms of the genitourinary system. The frequency of occurrence of bilateral RCC according to different authors is 2–6% of the total population of patients with RCC. Currently, the only effective method of treatment of bilateral RCC is surgical treatment. Patients with bilateral RCC are at high risk of dev eloping of local recurrence or progression of the disease after organ-preserving surgeries, which is why the surgeon is faced with a choice between a high risk of developing renal failure or relapse and/or progression of the disease, depending on the extent of the surgical intervention. According to the literature, in patients with bilateral RCC there was an increase in the incidence of papillary variant of RCC up to 19% and the presence of multifocal lesion. Surgical treatment of bilateral RCC is the only effective method to achieve satisfactory oncological results at a low incidence of complications. The m ost justified option for the treatment of bilateral RCC is the implementation of bilateral organ-preserving treatment, which allows achieving the optimal functional results. This article presents a clinical case of successful surgical treatment of a patient with bilateral RCC with multiple tumors.

1. International Agency for Research on Cancer. The globocan project: cancer incidence and mortality worldwide in 2012.

2. Kaprin AD, Starinskii VV, Petrova GV. (eds). Malignant neoplasms in Russia in 2015. Мoscow, 2017. Available at: http://www.oncology.ru/service/statistics/malignant_tumors/2015.pdf (In Russian).

3. Becker F, Siemer S, Tzavaras A, Suttmann H, Stoeckle M. Long-term Survival in Bilateral Renal Cell Carcinoma: A Retrospective Single-Institutional Analysis of 101 Patients After Surgical Urology. 2008 Aug; 72 (2): 349–53. DOI: 10.1016/j.urology.2008.04.001

4. Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes. BJU Int. 2007 Jul; 100 (1): 26–9. DOI: 10.1111/j.1464–410X.2007.06899.x

5. Simmons MN, Brandina R, Hernandez AF, Gill IS. Surgical Management of Bilateral Synchronous Kidney Tumors: Functional and Oncological Outcomes. J Urol. 2010 Sep; 184 (3): 865–72. DOI: 10.1016/j.juro.2010.05.042

6. Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, et al. Outcomes of Patients with Surgically Treated Bilateral Renal Masses and a Minimum of 10 Years of Followup. The J Urol. 2012 Dec; 188 (6): 2084–8. DOI: 10.1016/j.juro.2012.08.038

7. Alyayev YuG, Grigoryan ZG. Bilateral renal cancer. Cancer Urology. 2008; 3: 16–24. (In Russian).

8. Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateralrenal masses. Eur Urol. 2008 Oct; 54 (4): 855–63. DOI: 10.1016/j.eururo.2008.04.079

9. Klatte T, Wunderlich H, Patard J-J, Kleid MD, Lam JS, Junker K, et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 2007 Jul; 100 (1): 21–5. DOI: 10.1111/j.1464–410x.2007.06877.x

10. Lowrance WT, Yee DS, Cronin AM, Maschino AC, Bernstein M, Russo P.Evolution of the surgical management of bilateral renal masses. The Journal of Urology. 2009 Apr; 181 (4): 358. DOI: 10.1016/s0022–5347 (09)61014